Skip to content

Technology-Based Prevention for Adolescents in Primary Care

Technology-Based Prevention for Adolescents in Primary Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03489434
Enrollment
123
Registered
2018-04-05
Start date
2021-09-28
Completion date
2023-12-31
Last updated
2025-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use

Keywords

adolescents, primary care, sexual assault, substance use, sexual risk behavior

Brief summary

Adolescent substance use, sexual assault, and sexual risk behaviors pose a great public health concern, and subsequently there is also a great need to prevent these behaviors and experiences. This project involves the adaptation and integration of evidence-based prevention content aimed at preventing and reducing substance use, sexual assault, and sexual risk behaviors. This project uses innovative technology within primary care visits to conduct a feasibility trial of an integrated prevention program.

Detailed description

Pilot feasibility trial in preparation for RCT. Adolescents aged 14-18 will be recruited for screening from community-based primary care clinics to ensure ease of dissemination and representation of community-based primary care settings. The primary goal is to develop feasibility to apply for an R01 to conduct an RCT. Power analyses indicate that 280 participants would be needed for an RCT after accounting for attrition. Given that the RCT would be conducted over a 3-year period, a recruitment rate of 8 adolescents per month would indicate feasibility for a larger RCT.

Interventions

BEHAVIORALIntervention

Preliminary prevention program component content is based on evidence-based prevention programs and will integrate prevention content for substance use, sexual assault, and sexual risk behaviors.

Sponsors

Georgia State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Masking description

Participant and Investigator are blinded to condition

Eligibility

Sex/Gender
ALL
Age
14 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged 14-18 * Recent visit to primary care doctor

Exclusion criteria

* Inability to comprehend English independently due to disability or language

Design outcomes

Primary

MeasureTime frameDescription
Enrollment and Recruitment Ratewithin 2 year recruitment periodFeasibility of enrollment recruitment was assessed by the proportion of anticipated participants enrolled in the study
Retention Rate: Number of Participants Who Completed at Least 1 Follow-Up Studywithin 6 months of baseline participationFeasibility of retention was assessed by the proportion of participants retained in the study

Countries

United States

Participant flow

Participants by arm

ArmCount
Intervention Group
Preliminary prevention program component content is based on evidence-based prevention programs and will integrate prevention content for substance use, sexual assault, and sexual risk behaviors. Intervention: Preliminary prevention program component content is based on evidence-based prevention programs and will integrate prevention content for substance use, sexual assault, and sexual risk behaviors.
61
Control
Assessment only control.
62
Total123

Baseline characteristics

CharacteristicIntervention GroupControlTotal
Age, Continuous15.62 years
STANDARD_DEVIATION 1.39
15.63 years
STANDARD_DEVIATION 1.24
15.63 years
STANDARD_DEVIATION 1.31
Ever engaged in sex14 Participants13 Participants27 Participants
Race/Ethnicity, Customized
Asian
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Black or African American
59 Participants58 Participants117 Participants
Race/Ethnicity, Customized
Hispanic or Latine
1 Participants4 Participants5 Participants
Race/Ethnicity, Customized
Not Hispanic or Latine
46 Participants50 Participants96 Participants
Race/Ethnicity, Customized
Not listed or prefer not to answer
0 Participants2 Participants2 Participants
Race/Ethnicity, Customized
White
2 Participants1 Participants3 Participants
Region of Enrollment
United States
61 participants62 participants123 participants
Sex/Gender, Customized
Boy
31 Participants27 Participants58 Participants
Sex/Gender, Customized
Girl
28 Participants34 Participants62 Participants
Sex/Gender, Customized
Nonbinary
2 Participants1 Participants3 Participants
Substance use before sex in past 90 days1 Participants4 Participants5 Participants
Substance Use Risk
Alcohol
8 Participants8 Participants16 Participants
Substance Use Risk
Cannabis
8 Participants12 Participants20 Participants
Substance Use Risk
Illegal drugs
2 Participants1 Participants3 Participants
Substance Use Risk
Prescription drug misuse
8 Participants8 Participants16 Participants
Substance Use Risk
Tobacco or vaping
5 Participants5 Participants10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 610 / 62
other
Total, other adverse events
0 / 610 / 62
serious
Total, serious adverse events
0 / 610 / 62

Outcome results

Primary

Enrollment and Recruitment Rate

Feasibility of enrollment recruitment was assessed by the proportion of anticipated participants enrolled in the study

Time frame: within 2 year recruitment period

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention GroupEnrollment and Recruitment Rate61 Participants
ControlEnrollment and Recruitment Rate62 Participants
Primary

Retention Rate: Number of Participants Who Completed at Least 1 Follow-Up Study

Feasibility of retention was assessed by the proportion of participants retained in the study

Time frame: within 6 months of baseline participation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention GroupRetention Rate: Number of Participants Who Completed at Least 1 Follow-Up Study50 Participants
ControlRetention Rate: Number of Participants Who Completed at Least 1 Follow-Up Study54 Participants

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026